Atrial fibrillation risk of ibrutinib compared with that of chemotherapy, targeted therapy, and next-generation Bruton's tyrosine kinase inhibitors: Updated systematic review and meta-analysis - Jiale, Shi; Wei, Li; Huazhen, Liang; Hui-ping, Gong (Journal of Thoracic Disease; Online First, 2026)